You-lu Pan

Cyclin-dependent kinase-2 as a target for cancer therapy: progress in the development of CDK2 inhibitors as anti-cancer agents.

Tahir Ali Chohan, Jian-Zhong Chen, T. Chohan, 2014, Current medicinal chemistry.

Molecular simulation studies on the binding selectivity of 2-anilino-4-(thiazol-5-yl)-pyrimidines in complexes with CDK2 and CDK7.

T. Chohan, Haiyan Qian, You-lu Pan, 2016, Molecular bioSystems.

Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents.

Yin Zhao, You-lu Pan, Xinyue Zhang, 2014, Bioorganic & medicinal chemistry letters.

Molecular simulation studies on the binding activity and selectivity of 3-amino-phenyl-5-chloro-pyrimidine-2, 4-diamine derivatives in complexes with kinases c-Met and ALK

You-lu Pan, Jian-zhong Chen, Yan-ling Liu, 2018, Molecular Simulation.

Understanding the relative affinity and specificity of the substrate binding site of protein kinase B for substrate-mimetic inhibitors

Haiyan Qian, You-lu Pan, Shi-feng Chen, 2017 .

The progress of small-molecules and degraders against BCR-ABL for the treatment of CML.

You-lu Pan, Rongrong Hao, Zhengrong Shen, 2022, European journal of medicinal chemistry.

The Specific Cleavage of Lactone Linkage to Open-Loop in Cyclic Lipopeptide during Negative ESI Tandem Mass Spectrometry: The Hydrogen Bond Interaction Effect of 4-Ethyl Guaiacol

Yuanjiang Pan, Yuan-jiang Pan, You-lu Pan, 2014, PloS one.